AMAZON.COM INC (AMZN)       99.6496  -2.53 (-2.48%)

99.6496  -2.53 (-2.48%)

US0231351067 - Common Stock


Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AMZN. AMZN was compared to 80 industry peers in the Internet & Direct Marketing Retail industry. The financial health of AMZN is medium. Also its profitability is quite bad. AMZN shows excellent growth, but is valued quite expensive already.

Note: AMZN has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

AMZN has a Piotroski-F score of 4.00. This indicates an average health and profitability for AMZN.

VS Industry

Valuation

Valuation Rating

1

The PEG Ratio, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
When comparing the current price to the book value of AMZN, we can conclude it is valued correctly. It is trading at 6.99 times its book value.
The Price/Earnings Ratio is 107.15, which means the current valuation is very expensive for AMZN.
With a Price/Earning Ratio of 107.15, AMZN is valued a higher than the industry average, which is at 18.51. 97% of the companies listed in the same industry are cheaper than AMZN!

The Forward Price/Earnings Ratio of 57.85 indicates a quite expensive current valuation of AMZN.
Compared to an average industry price book ratio of 1.95, AMZN is valued more expensive than its industry peers. 88% of the companies listed in the same industry are valued cheaper.
Compared to an average industry Enterprise Value to EBITDA ratio of 13.36, AMZN is valued more expensive than its industry peers.
VS Industry

Price/Earnings (107.15) VS Industry: 3% outperformed.

207.59
2.00

Price/Book (6.99) VS Industry: 12% outperformed.

119.11
0.10

Enterprise Value/ EBITDA (19.37) VS Industry: 25% outperformed.

4,699.23
1.38

Growth

Growth Rating

7

AMZN shows a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 32.44% yearly.
The Earnings Per Share is expected to grow by 54.33% on average over the next 5 years. This is a very strong growth
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
Measured over the past 5 years, AMZN shows a very strong growth in Revenue. The Revenue has been growing by 23.64% on average per year.

The Revenue is expected to grow by 12.18% on average over the next 5 years. This is quite good.
Looking at the last year, AMZN shows a small growth in Revenue. The Revenue has grown by 9.40% in the last year.
AMZN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.62%.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS32.44% -6.88% -56.62% 85.43% 85.01% 63.85% 54.33%
Revenue23.64% 22.37% 9.4% 10.6% 12.46% 11.95% 12.18%

Health

Health Rating

4

AMZN has an Altman-Z score of 3.41. This indicates that AMZN is financially healthy and little risk of bankruptcy at the moment.
When comparing the Altman-Z score to an average industry score of 1.73, AMZN is in better financial health than the average industry peer.
The Piotroski-F score of AMZN is 4.00. This is a neutral score and indicates average health and profitability for AMZN.
AMZN has a Current Ratio of 0.94. This is a bad value and indicates that AMZN is not financially healthy enough and could expect problems in meeting its short term obligations.

Compared to an average industry Current Ratio of 1.57, AMZN is worse placed to pay its short term obligations than its industry peers. 83% of its industry peers have a better Current Ratio.
A Quick Ratio of 0.72 indicates that AMZN may have some problems paying its short term obligations.
When comparing the Quick Ratio of AMZN to the average industry Current Ratio of 1.06, AMZN is less able to pay its short term obligations than its industry peers.
When comparing the Debt to Equity Ratio of AMZN to the average industry Debt to Equity Ratio of 0.19, AMZN required more debt to finance its operations than its industry peers.
VS Industry

Debt/Equity (0.58) VS Industry: 29% outperformed.

27.95
0.00

Quick Ratio (0.72) VS Industry: 31% outperformed.

0.04
9.22

Current Ratio (0.94) VS Industry: 17% outperformed.

0.11
9.22

Altman-Z (3.41) VS Industry: 70% outperformed.

-34.83
14.29

Dividend

Dividend Rating

0

No dividends for AMZN!.

AMAZON.COM INC99.6496

NASDAQ:AMZN (2/7/2023, 10:31:09 AM)-2.53 (-2.48%)

Chartmill FA Rating
GICS Sector Consumer Discretionary
GICS IndustryGroup Retailing
GICS Industry Internet & Direct Marketing Retail
Earnings (Last) 02-02 2023-02-02/amc Earnings (Next) 04-26 2023-04-26/amc
Inst Owners 57.77% Inst Owner Change 0.28%
Ins Owners 9.76% Ins Owner Change -0.44%
Market Cap 1021.14B Analysts 84.56
Price Target 139.54 (40.03%)

Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y) N/A DP N/A
Div Incr Years N/A Div Non Decr Years N/A
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) -0.89%
Min EPS beat(2) -22.62% Max EPS beat(2) 20.85%
EPS beat(4) 2 Avg EPS beat(4) 1.81%
Min EPS beat(4) -22.62% Max EPS beat(4) 22.45%
Revenue beat(2) 1 Avg Revenue beat(2) -0.83%
Min Revenue beat(2) -2.23% Max Revenue beat(2) 0.57%
Revenue beat(4) 1 Avg Revenue beat(4) -0.93%
Min Revenue beat(4) -2.23% Max Revenue beat(4) 0.57%
PT rev (1m) -2.06% PT rev (3m) -5.63%
EPS NQ rev (1m) -8% EPS NQ rev (3m) -17.39%
EPS NY rev (1m) 0% EPS NY rev (3m) -27.18%
Revenue NQ rev (1m) -0.59% Revenue NQ rev (3m) -2.08%
Revenue NY rev (1m) 0% Revenue NY rev (3m) -1.2%

Valuation
Industry RankSector Rank
PE 107.15
Fwd PE 57.85
P/S 1.99
P/FCF N/A
P/OCF 21.84
P/B 6.99
P/tB 8.53
EV/EBITDA 19.37
EPS(TTM) 0.93 EY 0.93%
EPS(NY) 1.72 Fwd EY 1.73%
FCF(TTM) -1.65 FCFY N/A
OCF(TTM) 4.56 OCFY 4.58%
SpS 50.16 BVpS 14.25
TBVpS 11.68 PEG (NY) 1.25
PEG (5Y) 3.3

Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 3.49%
ROICexc 4.51%
ROICexgc 5.08%
OM 2.38%
PM N/A
GM 43.81%
ROICexgc(3y) 13.56% ROICexcg growth 3Y -36.66%
ROICexcg growth 5Y -18.31% ROICexc(3y) 11.53%
ROICexc growth 3Y -33.61% ROICexc growth 5Y -11.81%
OM growth 3Y -22.82% OM growth 5Y 0.64%
PM growth 3Y N/A PM growth 5Y N/A
GM growth 3Y 2.24% GM growth 5Y 3.4%
F-Score 4 Asset Turnover 1.11

Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA 1.63
Cap/Depr 151.82%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.72
Altman-Z 3.41
F-Score 4 WACC 9.41%
ROIC/WACC 0.54 Cap/Depr(3y) 162.93%
Cap/Depr(5y) 130.74% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -56.62% EPS 3Y -6.88%
EPS 5Y 32.44% EPS growth Q2Q -27.59%
EPS Next Y 85.43% EPS Next 2Y 85.01%
EPS Next 3Y 63.85% EPS Next 5Y 54.33%
Revenue growth 1Y 9.4% Revenue growth 3Y 22.37%
Revenue growth 5Y 23.64% Revenue growth Q2Q 8.58%
Revenue Next Year 10.6% Revenue Next 2Y 12.46%
Revenue Next 3Y 11.95% Revenue Next 5Y 12.18%
EBIT growth 1Y -50.77% EBIT growth 3Y -5.56%
EBIT growth 5Y 24.43% EBIT Next Year 630.46%
EBIT Next 3Y 117.57% EBIT Next 5Y 68.63%
FCF growth 1Y -14.72% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y 0.92%
OCF growth 3Y 6.67% OCF growth 5Y 20.55%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA